Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMPOWER Clinical Trial: Vagal Blocking for Obesity Control

NCT00521079 is registered in ClinicalTrials.gov with ReShape Lifesciences as lead sponsor.

NCT NCT00521079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00521079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMPOWER Clinical Trial: Vagal Blocking for Obesity Control
Lead sponsor
ReShape Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2007
Completion date
May 31, 2018
Enrollment
294 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

obesity